Skip to main content
Signal8

GARRETT SCOTT T

SEC insider (Form 3/4/5 filer). CIK 0001231174. Director at HCW Biologics Inc. (HCWB). 4 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in MIRAMAR,, FL.

Companies GARRETT SCOTT T has filed insider reports for

  • HCW Biologics Inc. (HCWB): Director
GARRETT SCOTT T profile photo

GARRETT SCOTT T

CIK: 0001231174

Transaction Breakdown

Open Market Buys (P)4 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HCW Biologics Inc. logo
HCWB

HCW Biologics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 22, 2026
    Purchase
    Indirect
    177.9K shares at avg. $1.41$250K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 16, 2025
    Purchase
    Direct
    13.4K shares at avg. $7.45$100K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 8, 2025
    Purchase
    Direct
    5.4K shares at avg. $26.00$140K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 7, 2025
    Purchase

    Common Stock Purchase Warrant

    Direct
    2.7K shares-

1-4 of 4